Related Experiment Video
Updated: Dec 3, 2025
07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.9K
Regulatory T Cells in the Tumor Microenvironment
Rebekah E Dadey1,2,3,4, Creg J Workman1,2,3, Dario A A Vignali5,6,7
1Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Advances in Experimental Medicine and Biology
|October 29, 2020
Summary
Regulatory T cells (Tregs) suppress immune responses and can hinder anti-tumor immunity by persisting in the tumor microenvironment. Targeting Tregs offers a promising therapeutic strategy for enhancing cancer treatments.
Area of Science:
- Immunology
- Oncology
Background:
- Regulatory T cells (Tregs) are crucial CD4+ T cells that maintain immune homeostasis by suppressing immune activation.
- Tregs are characterized by FOXP3 expression and high-affinity IL-2 receptor (CD25).
- Within the tumor microenvironment (TME), Tregs impede effective anti-tumor immunity.
Purpose of the Study:
- To provide a comprehensive overview of regulatory T cells (Tregs).
- To discuss the role of Tregs in the tumor microenvironment (TME).
- To explore therapeutic strategies targeting Tregs in cancer treatment.
Main Methods:
- Literature review and synthesis of current research on Tregs.
- Analysis of Treg recruitment, development, and function within the TME.
- Review of clinical applications and therapeutic targeting of Tregs.
Main Results:
- Tregs are key players in immune suppression and can establish within the TME.
- Treg presence in the TME poses a significant barrier to anti-tumor immune responses.
- Therapeutic targeting of Tregs is an emerging strategy in oncology.
Conclusions:
- Understanding Treg biology and function in the TME is critical for cancer immunotherapy.
- Targeting Tregs holds significant potential for improving cancer treatment efficacy.
- Future research directions include novel strategies for Treg modulation in the TME.
Related Concept Videos
02:17The Tumor Microenvironment
7.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
01:27Tumor Immunotherapy
1.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.1K
03:03mTOR Signaling and Cancer Progression
4.4K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.4K
01:24T Cell Types and Functions
1.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.8K
01:15Receptor Downregulation in MVBs
2.6K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.6K
02:23Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K